The Valley Desk

ReviewThe oncologistPublished

Considerations for the practical management of cardiovascular risk with Bruton's tyrosine kinase inhibitors for patients with chronic lymphocytic leukemia

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Hospital of the University of Pennsylvania, Perelman School of Medicine, University of Pennsylvania, with Penn Medicine linked by the institution reference. Affiliation source

Publication record

Type
Review
Venue
The oncologist
Published
Subject terms
Humans; Cardiovascular Diseases; Benzamides; Piperidines; Pyrazines; Pyrazoles; Pyrimidines; Adenine; Protein Kinase Inhibitors; Leukemia, Lymphocytic, Chronic, B-Cell; Agammaglobulinaemia Tyrosine Kinase; Tyrosine Kinase Inhibitors
PubMed ID
40737507
PubMed Central ID
PMC12548057
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal